Timing of adjuvant chemotherapy and tamoxifen in women with breast cancer: findings from two consecutive trials of Gruppo Oncologico Nord-Ovest–Mammella Intergruppo (GONO-MIG) Group
Lucia Del Mastro(Ospedale Policlinico San Martino), M. Venturini, T. Catzeddu(Associazione Italiana Di Oncologia Medica), Paolo Bruzzi(Alleanza Contro il Cancro), Giovanna Cavazzini(University of Padua), P. Pronzato(Accademia Nazionale dei Lincei), Béatrice Dozin(Ospedale Policlinico San Martino), Silvio Danese(IRCCS Ospedale San Raffaele), Giuseppe Canavese(Ente Ospedaliero Ospedali Galliera), Editta Baldini, Antonio Durando(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Enrico Aitini, A. Contu(Ente Ospedaliero Ospedali Galliera)
Cited by 20
Related Papers
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
|Gastroenterology|2021|2.6k
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2023|830